GKB Ophthalmics Ratios

GKB Ophthalmics Ltd Ratios

The GKB Ophthalmics Ltd Ratios page provides a complete fundamental analysis of GKB Ophthalmics Ltd using key valuation, profitability, and financial strength metrics. Investors tracking GKB Ophthalmics Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

GKB Ophthalmics Ltd (NSE: GKB, BSE: 533212) is currently trading at ₹58.86, with a market capitalization of ₹296.69M. As a major player in the Health technology sector and Medical specialties industry, GKB Ophthalmics Ltd remains a key stock for fundamental analysis using GKB Ophthalmics Ltd Ratios.

GKB Ophthalmics Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The GKB Ophthalmics Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in GKB Ophthalmics Ltd Ratios.

Historically, the GKB Ophthalmics Ltd P/E ratio has shown strong fluctuations:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 36.39
• 2020: 0

The decline in GKB Ophthalmics Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The GKB Ophthalmics Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.59.

Historical P/B trend:

• 2024: 0.59
• 2023: 0.74
• 2022: 0.88
• 2021: 0.74

GKB Ophthalmics Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The GKB Ophthalmics Ltd P/S ratio currently stands at 0.28, an important part of GKB Ophthalmics Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 0.28
• 2023: 0.50
• 2022: 0.73
• 2021: 0.65

A stable or declining GKB Ophthalmics Ltd P/S ratio indicates cautious market sentiment.

GKB Ophthalmics Ltd Price to Cash Flow Ratio (P/CF)

The GKB Ophthalmics Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical GKB Ophthalmics Ltd Price to Cash Flow Ratio:

• 2024: 0
• 2023: 10.50
• 2022: 0
• 2021: 12.39
• 2020: 0

The declining GKB Ophthalmics Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

GKB Ophthalmics Ltd Enterprise Value Ratios

Enterprise Value (EV)

The GKB Ophthalmics Ltd EV currently stands at ₹354.89M, representing the total company valuation including debt.

Historical EV trend:

• 2024: 354.89M
• 2023: 420.46M
• 2022: 560.8M
• 2021: 460.5M

GKB Ophthalmics Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The GKB Ophthalmics Ltd EV/EBITDA ratio is currently 0, a key metric in GKB Ophthalmics Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 0
• 2023: 72.61
• 2022: 15.41
• 2021: 9.43

Stable GKB Ophthalmics Ltd EV/EBITDA indicates balanced valuation.

GKB Ophthalmics Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The GKB Ophthalmics Ltd D/E ratio is currently 0.28, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.28
• 2023: 0.19
• 2022: 0.18
• 2021: 0.19

GKB Ophthalmics Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The GKB Ophthalmics Ltd ROE currently stands at -12.65%, showing profitability and capital efficiency.

Historical ROE:

• 2024: -12.65
• 2023: -4.61
• 2022: -0.27
• 2021: 2.03

Declining ROE indicates pressure on profitability.

GKB Ophthalmics Ltd Ratios Analysis Summary

The GKB Ophthalmics Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether GKB Ophthalmics Ltd stock is undervalued, fairly valued, or overvalued.

Tracking GKB Ophthalmics Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.